News

Research organisations join forces to develop treatments for neglected infectious diseases

BMJ 2008; 336 doi: 10.1136/bmj.a389 (Published 19 June 2008)
Cite this as: BMJ 2008;336:1396.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Susan Mayor, London

    Two research organisations based in Paris, the Institut de Recherche pour le Développement (Institute of Research for Development) and the Drugs for Neglected Diseases Initiative, have announced that they will work together to develop new candidate drugs to treat visceral leishmaniasis, Chagas’s disease, and sleeping sickness.

    The collaboration will focus on the development of two types of molecules: quinolines for visceral leishmaniasis and canthin-6-one alkaloids for Chagas’s disease. Researchers working at the Institut de Recherche pour …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular